â– LECTURE OVERVIEW: Organophosphate poisoning is a life-threatening toxidrome resulting from severe, uninhibited acetylcholinesterase inactivation that triggers massive cholinergic hyperstimulation.
â– MOLECULAR TOXICOLOGY & ACTIONS:
1. Phosphorylation of active site: Organophosphates (found in agricultural insecticides like parathion, malathion and nerve gases like sarin) bind covalently to the serine hydroxyl group of acetylcholinesterase (AChE), neutralizing the enzyme.
2. Acetylcholine Overdrive: Acetylcholine accumulates in synaptic clefts across muscarinic, nicotinic, and central nervous system synapses.
3. Cholinergic Excess (DUMBBELSS): Drives a massive cholinergic crisis: Diarrhea, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation, and Sweating. Nicotinic accumulation causes muscle fasciculations, muscle fatigue, flaccid paralysis (diaphragm failure), and central respiratory depression.
4. Chemical Aging: Over hours, the covalent bond undergo dealkylation ('aging'), rendering the AChE chemical blockade completely permanent and irreversible.
â– PHYSIOLOGICAL METABOLIC RECOVERY LOOPS:
Intense pathologic strain initiates systemic arterial, neural, or renal neurohormonal feedback mechanisms to maintain oxygenation, cellular pH balance, and blood pressure in critical territories.
â– MOLECULAR PATHWAY DYNAMICS:
Intracellular cascades undergo profound modifications, altering secondary transcription levels and receptor presentation on cellular membranes.
[HY-BOARD-1080]
🌟 Dynamic Clinical Key:
Management requires a rapid, dual-action antidote: Atropine (a competitive muscarinic blocker) to address life-threatening bradycardia and bronchospasm, and Pralidoxime (2-PAM), an oxime compound designed to dephosphorylate and regenerate active AChE. Crucially, Pralidoxime must be administered before AChE 'aging' occurs to be effective. Recognize that blocking some compensatory mechanisms (like reducing hyperventilation in respiratory compensation) can hasten acidotic collapse. Therapeutic molecules targeting upstream signaling components demonstrate superior efficacy profiles.